Sector portfolio · VC firm · Netherlands
EQT Life Sciences' Biotech portfolio
EQT Life Sciences has backed 30 Biotech startups in rounds we track, $2.9B between them, shown by the stage each has reached. The best-funded is Tubulis.
30startups backed
4stages
$2.9Braised between them
Series Bbiggest stage
Funding by segment
- Series B$707M9
- Stage not reported$504M8
- Series A$723M8
- Series C and later$953M5
Where they are based
- United States7$490M
- Switzerland5$691M
- France4$307M
- Germany4$533M
- United Kingdom4$477M
- Netherlands3$175M
- Belgium2$151M
- Denmark1$62M
United States
Switzerland
France
Germany
United Kingdom
Netherlands
Belgium
DenmarkFounded
1Earlier
112
213
114
415
316
117
118
819
420
121
22
123
24
25
26
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M7
- $50M to $250M21
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
28 of 30 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States7
- Switzerland5
- France4
- Germany4
- United Kingdom4
- Netherlands3
- Belgium2
- Denmark1
Startups by country, 8 countries in all.
Segment by segment
Series B
9 startups · $707M raised
Noema PharmaNoema Pharma is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 by George Garibaldi and Luigi Costa.Switzerland$147M
ImCheck TherapeuticsImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.France$97M
Atalanta TherapeuticsAtalanta Therapeutics is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies for ceUnited States$97M
QurAlisQurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.United States$94M
Cardior PharmaceuticalsCardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.Germany$92M
XyloCor TherapeuticsXyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.United States$68M
DNA ScriptDNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.France$62M
etherna immunotherapieseTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system.Belgium$39M
Stage not reported
8 startups · $504M raised
Tenpoint TherapeuticsTenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.United Kingdom$150M
EvommuneEvommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.United States$125M
AviadoBioAviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene tUnited Kingdom$93M- MMinervaxDenmark$62M
VarmXVarmX B.V.Netherlands$25M
Visus TherapeuticsVisus Therapeutics is a clinical-stage company developing innovative medicines.United States$20M
XilisXilis is an oncology and precision health company that provides technologies to diagnoses cancer.United States$19M
Egle TherapeuticsEgle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.France$9.4M
Series A
8 startups · $723M raised
Arvelle TherapeuticsArvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.Switzerland$223M
VectorYVectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020.Netherlands$138M
AstronauTxAstronauTx Ltd.United Kingdom$124M- MTMosanna TherapeuticsSwitzerland$80M
Shinobi TherapeuticsShinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.United States$68M
FoRx TherapeuticsFoRx Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.Switzerland$50M
Ariceum TherapeuticsAriceum Therapeutics is a private, clinical-stage radiopharmaceutical company based in Berlin, Germany.Germany$25M
LuxendoLuxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.Germany$15M
Series C and later
5 startups · $953M raised
TubulisTubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.Germany$401M
NouscomNouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities iSwitzerland$191M- APAmolyt PharmaAmolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.France$139M
AgomAB TherapeuticsAgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.Belgium$112M
PhagenesisPhagenesis Ltd.United Kingdom$110M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names EQT Life Sciences as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCo-investorsWho invests with EQT Life Sciences33 co-investorsSector portfolioTrue Ventures' AI portfolio50 startups · $1.9BSector portfolioEIT InnoEnergy's Energy portfolio20 startups · $289MSector portfolioMaven 11 Capital's Web3 & Crypto portfolio19 startups · $161MSector portfolioProsus Ventures' AI portfolio17 startups · $374MSector portfolioTrue Ventures' Fintech portfolio13 startups · $423M
Raising from investors like EQT Life Sciences?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.